MedTrace Logo

Use of Rapid Diagnostic Tests for Malaria Case Management in Kenya

NCT00336388 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3600

Last updated 2010-03-09

No results posted yet for this study

Summary

The purpose of this study is to investigate the impact of rapid diagnostic tests (RDTs) in the context of a newly implemented malaria case management guidelines using artemisinin-based combination therapy on the malaria prescribing practices of health care workers in Kenya.

Conditions

Interventions

DEVICE

Paracheck Device

Sponsors & Collaborators

  • Kenya Medical Research Institute

    collaborator OTHER

  • Kenya Division of Malaria Control

    collaborator UNKNOWN

  • KEMRI-Wellcome Trust Collaborative Research Program

    collaborator OTHER

  • Centers for Disease Control and Prevention

    lead FED

Principal Investigators

  • Mary Hamel, MD · Centers for Disease Control and Prevention

  • Alexandre Macedo De Oliveira, MD · Centers for Disease Control and Prevention

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
5 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-07-31
Primary Completion
2006-09-30
Completion
2006-09-30

Countries

  • Kenya

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00336388 on ClinicalTrials.gov